Navigation Links
PTC Therapeutics to Showcase Breadth of Pipeline at Upcoming R&D Day
Date:10/19/2013

SOUTH PLAINFIELD, N.J., Oct. 18, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it will hold its first R&D Day on Friday, October 25, 2013 from 8:30 a.m. to 12:00 p.m. ET at the Four Seasons Hotel in New York City. Members of PTC's senior management and research teams will provide a corporate update and in-depth reviews of the company's scientific platforms and R&D programs.

(Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

A live webcast of the event will be available on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at www.ptcbio.com. The presentation will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.       
PTC is biopharmaceutical company focused on the discovery and development of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and form the basis for collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com  

Forward Looking State
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 Today the Council ... 150 major food companies, retailers, and human and ... on Antibiotic Stewardship. CSTE is committed to supporting ... detect resistant strains, preserve the efficacy of our ... infections. CSTE continues to serve as ...
(Date:6/2/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... from the U.S. Food and Drug Administration (FDA) of ... Oral Solution 5mg/5mL. Trailing twelve-month sales for the product ... competitors. ANI expects to begin shipping to its customers ... and CEO of ANI Pharmaceuticals, stated, "This ANDA represents ...
(Date:6/2/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... with ORMD-0801, its orally ingestible insulin capsule on type ... sessions in the ADA 75 th Scientific Sessions ... . The poster will be attended by Oramed,s Chief ...
Breaking Medicine Technology:ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 2ANI Pharmaceuticals Announces FDA Approval of Oxycodone Hydrochloride Oral Solution 5mg/5mL 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 2Oramed to Present at the American Diabetes Association 75th Scientific Sessions 3Oramed to Present at the American Diabetes Association 75th Scientific Sessions 4
(Date:6/2/2015)... June 02, 2015 The Down Syndrome ... Potter from the hit show Glee as the keynote ... Walk in Pleasant Prairie, WI. The event aims to ... in Racine, Kenosha, and Walworth counties. ... join us for this important event," says Dawn Nuoffer, ...
(Date:6/2/2015)... York, NY (PRWEB) June 02, 2015 ... Profemur hip replacement lawsuit ( http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) is ... County. According to court documents, opening statements were ... asserting that laser etchings on the Profemur hip ... fracture, causing it to snap just three years ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Tronics, a ... deploying its growth strategy to benefit from the significant ... Yole Développement’s May 2015 Status of the MEMS Industry ... sharply and reach $6.6B in 2020,” says Frederic Breussin, ... Développement . , The analyst adds that “although the ...
(Date:6/2/2015)... ANT Wireless, proven innovator in ultra-low power ... new products implementing the ANT+ Fitness Equipment Control (FE-C) ... in their bike trainer products, built to create an ... the FE-C device profile in its Vortex Smart and ... indoor training software, while Kinomap has added FE-C support ...
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
Breaking Medicine News(10 mins):Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:Tronics Aims to Benefit from Major Growth of Sensors and Related Technologies for Healthcare Applications 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 2Health News:First ANT FE-C Enabled Fitness Products Enter Market 3Health News:Acara Partners Expands Website and Digital Offerings 2
... with Medtronic delivery and glucose sensing leadership INDIANAPOLIS and ... names in diabetes management -Eli Lilly and Company (NYSE: ... MDT ) - today announced a strategic marketing ... with diabetes manage their blood sugar using insulin therapy.Working ...
... and Data Management Providers Expands Area Market RoleSANTA ... a leading provider of digital radiography (DR), ultrasound, ... management software (VIA(R)) for veterinary care, announced it ... West Coast ultrasound representative. Thorn brings strong animal ...
... brain ,sings, could improve our understanding of conditions such ... scientists at Cardiff University have discovered. , Research ... Imaging Centre (CUBRIC) has discovered that a person,s brain ... when a person looks at a visual pattern. ...
... Television Infrastructure to Enable System Turn-On At Grand ... May 19 LodgeNet Healthcare, a division of ... and the leading provider of interactive patient television ... Television System is now serving patients at the ...
... Policy Actions at the Federal Level , ... (PRWEB) ... more than 200 viral hepatitis groups around the world have planned ... support for improvements in prevention, diagnosis, treatment and support for people ...
... May 19 The Quigley Corporation, (Nasdaq: ... www.quigleyco.com , today announced that it has ... the Company,s Quigley Pharma, Inc. wholly-owned subsidiary COO, Dr. ... of documentary evidence of undisclosed payments from Karkus to ...
Cached Medicine News:Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 2Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 3Health News:Lilly and Medtronic Form Alliance to Provide Solutions for Diabetes Management 4Health News:Eklin Medical Systems Appoints Juan Thorn as West Coast Ultrasound Sales Representative 2Health News:'Singing brains' offers epilepsy and schizophrenia clues 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 2Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 2Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 4Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 5
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
... generation of a hypoxic environment for tissue ... surface-type seal where all portions of the ... steel ring clamp for a reliable air-tight ... and bottom provide minimum gas flow resistance ...
... range of miniTHERM incubators is available, ensuring ... solution for their specific requirements. miniTHERM incubators ... compact and extremely space saving. Their size ... It is possible to stack up to ...
... Steri-Cult has been the leading ... volume cell culture for more ... the name that brought leading ... CO 2 sensors,microprocessor control, ...
Medicine Products: